levetiracetam altan pharma 100 mg/ml inf. sol. (conc.) i.v. vial
altan pharma ltd. - levetiracetam 500 mg/5 ml - concentrate for solution for infusion - 100 mg/ml - levetiracetam 100 mg/ml - levetiracetam
levobupivacaïne altan pharma 0,625 mg/ml inf. sol. epidur.
altan pharma ltd. - levobupivacaine hydrochloride 0,704 mg/ml - eq. levobupivacaine 0,625 mg/ml - solution for infusion - 0,625 mg/ml - levobupivacaine hydrochloride 0.704 mg/ml - levobupivacaine
levobupivacaïne altan pharma 1,25 mg/ml inf. sol. epidur.
altan pharma ltd. - levobupivacaine hydrochloride 1,41 mg/ml - eq. levobupivacaine 1,25 mg/ml - solution for infusion - 1,25 mg/ml - levobupivacaine hydrochloride 1.41 mg/ml - levobupivacaine
levobupivacaïne altan pharma 2,5 mg/ml inj./inf. sol. epidur./i.thec. amp.
altan pharma ltd. - levobupivacaine hydrochloride 2,816 mg/ml - eq. levobupivacaine 2,5 mg/ml - solution for injection/infusion - 2,5 mg/ml - levobupivacaine hydrochloride 2.816 mg/ml - levobupivacaine
levobupivacaïne altan pharma 5 mg/ml inj./inf. sol. epidur./i.thec. amp.
altan pharma ltd. - levobupivacaine hydrochloride 5,633 mg/ml - eq. levobupivacaine 5 mg/ml - solution for injection/infusion - 5 mg/ml - levobupivacaine hydrochloride 5.633 mg/ml - levobupivacaine
levobupivacaïne altan pharma 7,5 mg/ml inj./inf. sol. epidur./i.thec. amp.
altan pharma ltd. - levobupivacaine hydrochloride 8,449 mg/ml - eq. levobupivacaine 7,5 mg/ml - solution for injection/infusion - 7,5 mg/ml - levobupivacaine hydrochloride 8.449 mg/ml - levobupivacaine
teicoplanine altan pharma 200 mg inj./inf. sol. (pwdr. + solv.)/or. sol. (pwdr. + solv.) i.v./i.m. vial + amp.
altan pharma ltd. - teicoplanin 200 mg - powder and solvent for solution for injection/infusion; powder and solvent for oral solution - 200 mg - teicoplanin 200 mg - teicoplanin
teicoplanine altan pharma 400 mg inj./inf. sol. (pwdr. + solv.)/or. sol. (pwdr. + solv.) i.v./i.m. vial + amp.
altan pharma ltd. - teicoplanin 400 mg - powder and solvent for solution for injection/infusion; powder and solvent for oral solution - 400 mg - teicoplanin 400 mg - teicoplanin
levobupivacaïne altan pharma 1,25 mg/ml inf. sol. epidur.
altan pharma ltd. - levobupivacaine hydrochloride 1,41 mg/ml - eq. levobupivacaine 1,25 mg/ml - solution for infusion - levobupivacaine
atosiban altan
propharm ltd - atosiban - solution for injection/ concentrate for solution for infusion - atosiban 7.5 mg / 1 ml - atosiban - atosiban altan is indicated to delay imminent pre-term birth in pregnant women with: - regular uterine contractions of at least 30 seconds duration at a rate of 4 or more per 30 minutes- a cervical dilation of 1 to 3 cm (0-3 for nulliparas) and effacement of 50 % or more - age: 18 years and above - a gestational age from 24 until 33 completed weeks - a normal foetal heart rate